|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
C26.9 |
Malignant neoplasm of ill-defined sites within the digestive system
|
C269 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 38.36%
|
30.23%
|
14.32%
|
6.61%
|
3.46%
|
3.04%
|
1.14%
|
0.91%
|
0.34%
|
0.34%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C26.9*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
446
|
446
|
|
80053
|
COMPREHEN METABOLIC PANEL |
418
|
418
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
342
|
344
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
330
|
330
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
215
|
20,724
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
211
|
211
|
|
71260
|
CT THORAX DX C+ |
162
|
162
|
|
G1004
|
CDSM NDSC |
117
|
150
|
|
82378
|
CARCINOEMBRYONIC ANTIGEN |
85
|
85
|
|
83735
|
ASSAY OF MAGNESIUM |
82
|
82
|
|
96413
|
CHEMO IV INFUSION 1 HR |
80
|
80
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
74
|
132
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
69
|
928
|
|
82565
|
ASSAY OF CREATININE |
66
|
66
|
|
J9190
|
FLUOROURACIL INJECTION |
60
|
273
|
|
J1642
|
INJ HEPARIN SODIUM PER 10 U |
56
|
2,435
|
|
J9263
|
OXALIPLATIN |
49
|
7,340
|
|
A9698
|
NON-RAD CONTRAST MATERIALNOC |
48
|
61
|
|
84443
|
ASSAY THYROID STIM HORMONE |
46
|
47
|
|
85610
|
PROTHROMBIN TIME |
45
|
45
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C26.9 related to the following DRG Codes:
374-376
|
